This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile PlanDefinition.
Generated Narrative: PlanDefinition
Resource PlanDefinition "opioidcds-05"
url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-05
identifier: id: urn:oid:2.16.840.1.113883.4.642.11.1, id: cdc-opioid-guidance (OFFICIAL)
version: 0.1.0
name: cdc-opioid-05
title: CDC Opioid Prescribing Guideline Recommendation #5
type: ECA Rule (PlanDefinitionType#eca-rule)
status: draft
date: 2017-04-23
publisher: Centers for Disease Control and Prevention (CDC)
description: When opioids are started, providers should prescribe the lowest effective dosage.
- | Code | Value[x] |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Medication requested (situation) (SNOMED CT#182888003) |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Chronic pain (finding) (SNOMED CT#82423001) |
jurisdiction: United States of America (unknown#US)
purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.
usage: Providers should use caution when prescribing opioids at any dosage, should carefully reassess evidence of individual benefits and risks when considering increasing dosage to ≥50 morphine milligram equivalents (MME)/day, and should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to >90 MME/day
copyright: © CDC 2016+.
topic: Opioid Prescribing ()
author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:
relatedArtifact
type: documentation
display: CDC guideline for prescribing opioids for chronic pain
relatedArtifact
type: documentation
display: MME Conversion Tables
library: http://example.org/fhir/Library/opioidcds-recommendation-05
action
title: High risk for opioid overdose.
description: Total morphine milligram equivalent (MME) exceeds recommended amount. Taper to less than 50.
documentation
type: documentation
Triggers
- Type Name * named-event medication-prescribe condition
kind: applicability
Expressions
- Description Language Expression * Is total MME >= 50? text/cql Is MME 50 Or More? groupingBehavior: visual-group
selectionBehavior: exactly-one
dynamicValue
path: action.title
Expressions
- Language Expression * text/cql getSummary dynamicValue
path: action.description
Expressions
- Language Expression * text/cql getDetail dynamicValue
path: activity.extension
Expressions
- Language Expression * text/cql getIndicator Actions
- Description * Will reduce dosage * Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo * Acute pain; snooze 1 mo * N/A - see comment (will be reviewed by medical director); snooze 3 mo
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.